Baocai Xing

682 citations
11 papers · 520 indexed · h-index 6
    • Cancer, Hypoxia, and Metabolism 3
    • Cancer, Lipids, and Metabolism 3
  • Spectroscopy top 10%
    • Advanced Proteomics Techniques and Applications 3
    • Hepatocellular Carcinoma Treatment and Prognosis 2
    • Biochemical and Molecular Research 2
    • RNA modifications and cancer 1
    • Metabolomics and Mass Spectrometry Studies 1
    • Cancer Research and Treatments 1

Baocai Xing

8 papers receiving 514 citations

Peers

Baocai Xing
Comparison fields: 5 of 74
  • Cancer Research 117
  • Immunology 124
  • Spectroscopy 80
  • Hepatology 37
  • Molecular Biology 289
Replace Rui‐xia Sun with:
Rui‐xia Sun China
Katharina Malinowsky Germany
Song Zhao China
Ju-Tao Feng China
Christopher Toth United States
Hye-Jin Sung South Korea
Parunya Chaiyawat Thailand
Hong Shen China
Xun‐Xun Wan China
Baocai Xing relative to Rui‐xia Sun China Rui‐xia Sun's profile →
Citations per field
00.5×3.8×
Rui‐xia Sun · 1×
Citations per year

Countries citing papers authored by Baocai Xing

Since Specialization
Citations

This map shows the geographic impact of Baocai Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baocai Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baocai Xing more than expected).

Fields of papers citing papers by Baocai Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baocai Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baocai Xing. The network helps show where Baocai Xing may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Baocai Xing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Baocai Xing Line = papers co-authored together Baocai Xing links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1 20250
2 20254
3 20250
4 20250
5 20242
6 202250
7 202046
8 201741
9 2016122
10 200844
11 2007211

About Baocai Xing

Baocai Xing is a scholar working on Cancer Research, Hepatology and Spectroscopy, having authored 11 papers that have together received 520 indexed citations. Recurring topics across this work include Advanced Proteomics Techniques and Applications (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer, Lipids, and Metabolism (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Biochemical and Molecular Research (2 papers), RNA modifications and cancer (1 paper), Metabolomics and Mass Spectrometry Studies (1 paper) and Cancer Research and Treatments (1 paper). The work is most often cited by research in Cancer Research (117 citations), Immunology (124 citations) and Spectroscopy (80 citations). Baocai Xing has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Xiaojuan Du, Fuchu He, Wei Sun, Min Lu, Ying Jiang, Xiaohong Qian, Handong Wei, Yunping Zhu, Yi Sun and Wei Mi. Their work appears in journals such as British Journal of Cancer, Annals of Oncology and Molecular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026